After analyzing the recent headlines about DRREDDY, I conclude that:

Final Decision: BUY
Reason: Despite a 0.8% drop in net profit, the company's revenue grew 14% YoY, driven by its generic business, and the announcement of a 1:5 stock split and major fund infusion are positive signals, indicating a strong growth trajectory.